AR060566A1 - Tratamiento de melanoma - Google Patents
Tratamiento de melanomaInfo
- Publication number
- AR060566A1 AR060566A1 ARP070101722A ARP070101722A AR060566A1 AR 060566 A1 AR060566 A1 AR 060566A1 AR P070101722 A ARP070101722 A AR P070101722A AR P070101722 A ARP070101722 A AR P070101722A AR 060566 A1 AR060566 A1 AR 060566A1
- Authority
- AR
- Argentina
- Prior art keywords
- melanoma
- subject
- immunomodulatory compound
- inhibiting
- treating
- Prior art date
Links
- 201000001441 melanoma Diseases 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000002519 immonomodulatory effect Effects 0.000 abstract 3
- 206010027476 Metastases Diseases 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 108010033276 Peptide Fragments Chemical group 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 101710188315 Protein X Chemical group 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- -1 heterocyclic amino acid Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se administra un compuesto inmunomodulador para tratar, prevenir, inhibir o reducir melanoma en un sujeto. Reivindicacion 1: Un procedimiento de utilizacion de un compuesto inmunomodulador de formula (1) donde, n es 1 o 2, R es hidrogeno, acilo, alquilo o un fragmento peptídico, y X es un aminoácido aromático o heterocíclico o un derivado de éste, para la manufactura de un medicamento que comprende un compuesto inmunomodulador de formula (1) para tratar, prevenir, inhibir o reducir melanoma o metástasis de éste en el sujeto o tratar, prevenir, inhibir, o reducir el crecimiento de dichas células de melanoma o metástasis de éstos en el sujeto.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79324306P | 2006-04-20 | 2006-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR060566A1 true AR060566A1 (es) | 2008-06-25 |
Family
ID=38625521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070101722A AR060566A1 (es) | 2006-04-20 | 2007-04-20 | Tratamiento de melanoma |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8163702B2 (es) |
| EP (1) | EP2029154A4 (es) |
| JP (1) | JP2009534383A (es) |
| CN (1) | CN101448514A (es) |
| AR (1) | AR060566A1 (es) |
| AU (1) | AU2007240946A1 (es) |
| BR (1) | BRPI0711567A2 (es) |
| CA (1) | CA2649575A1 (es) |
| EA (1) | EA016660B1 (es) |
| IL (1) | IL194798A0 (es) |
| MX (1) | MX2008013329A (es) |
| TW (1) | TW200808337A (es) |
| WO (1) | WO2007123847A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090074815A1 (en) * | 2005-04-22 | 2009-03-19 | Sciclone Pharmaceuticals, Inc. | Immunomodulator Compounds as Vaccine Enhancers |
| JP2010518160A (ja) * | 2007-02-13 | 2010-05-27 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | 粘膜の疾患による組織の崩壊、傷害又は損傷を治療又は予防する方法 |
| RU2615908C1 (ru) * | 2016-05-16 | 2017-04-11 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ моделирования лимфогенного и гематогенного метастазирования мышиной меланомы В16 у белых нелинейных крыс |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4758551A (en) * | 1986-07-08 | 1988-07-19 | Cornell Research Foundation, Inc. | Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types |
| GB9320820D0 (en) * | 1993-10-08 | 1993-12-01 | Biokine Tech Ltd | Compounds for medicinal use |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| WO1997019691A1 (en) | 1995-11-28 | 1997-06-05 | Wei, Edward, T. | Gamma-l-glutamyl containing immunomodulator compounds and methods therewith |
| US5916878A (en) * | 1995-11-28 | 1999-06-29 | Edward T. Wei | γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith |
| US5744452A (en) * | 1995-11-28 | 1998-04-28 | Edward T. Wei | γ-L-glutamyl containing immunomodulator compounds and methods therewith |
| RU2091389C1 (ru) | 1995-11-28 | 1997-09-27 | Товарищество с ограниченной ответственностью "Верта" | Пептид, обладающий иммуномодулирующей активностью |
-
2007
- 2007-04-13 MX MX2008013329A patent/MX2008013329A/es not_active Application Discontinuation
- 2007-04-13 EP EP07755352A patent/EP2029154A4/en not_active Withdrawn
- 2007-04-13 WO PCT/US2007/009049 patent/WO2007123847A2/en not_active Ceased
- 2007-04-13 CA CA002649575A patent/CA2649575A1/en not_active Abandoned
- 2007-04-13 AU AU2007240946A patent/AU2007240946A1/en not_active Abandoned
- 2007-04-13 BR BRPI0711567-9A patent/BRPI0711567A2/pt not_active Application Discontinuation
- 2007-04-13 CN CNA2007800185364A patent/CN101448514A/zh active Pending
- 2007-04-13 EA EA200802136A patent/EA016660B1/ru not_active IP Right Cessation
- 2007-04-13 US US12/297,699 patent/US8163702B2/en not_active Expired - Fee Related
- 2007-04-13 JP JP2009506516A patent/JP2009534383A/ja active Pending
- 2007-04-20 TW TW096114143A patent/TW200808337A/zh unknown
- 2007-04-20 AR ARP070101722A patent/AR060566A1/es unknown
-
2008
- 2008-10-22 IL IL194798A patent/IL194798A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200802136A1 (ru) | 2009-04-28 |
| JP2009534383A (ja) | 2009-09-24 |
| EP2029154A4 (en) | 2012-04-04 |
| IL194798A0 (en) | 2011-08-01 |
| TW200808337A (en) | 2008-02-16 |
| CA2649575A1 (en) | 2007-11-01 |
| MX2008013329A (es) | 2008-11-18 |
| EA016660B1 (ru) | 2012-06-29 |
| CN101448514A (zh) | 2009-06-03 |
| AU2007240946A1 (en) | 2007-11-01 |
| US8163702B2 (en) | 2012-04-24 |
| BRPI0711567A2 (pt) | 2011-11-08 |
| WO2007123847A2 (en) | 2007-11-01 |
| US20090088392A1 (en) | 2009-04-02 |
| EP2029154A2 (en) | 2009-03-04 |
| WO2007123847A3 (en) | 2008-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201391705A1 (ru) | Триазолпиридиновые ингибиторы 11-бета-гидроксистероиддегидрогеназы типа i | |
| EA200971104A1 (ru) | Производные бензимидазола | |
| SI2020996T1 (sl) | Postopek in sestavki za zdravljenje hematološkihmalignosti | |
| IL198979A (en) | Enzyme inhibitors diacylglycerol o-acetyltransferase type 1 | |
| JO2848B1 (en) | Organic compounds | |
| BR0314699A (pt) | Composto, composição e métodos para o tratamento da dor e para inibição da função vr1 em uma célula | |
| DE602007014186D1 (de) | Triazin-11-beta-hydroxysteroid-dehydrogenase-artige hemmer | |
| MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
| WO2010093849A3 (en) | Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions | |
| IL189694A0 (en) | Biphenyl derivatives and their use in treating hepatitis c | |
| BR122018007328B8 (pt) | composto, composição farmaceutica e uso do dito composto | |
| PH12013500913A1 (en) | Substituted-quinoxaline-type-piperidine compounds and the uses thereof | |
| ATE533489T1 (de) | Behandlung von multiplem myelom | |
| UA96777C2 (ru) | Фенилпропионамидные соединения и их применение как опиоидных агонистов | |
| MX2009011601A (es) | Agentes terapeuticos utiles para tratar el dolor. | |
| DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus | |
| MX2010007584A (es) | Inhibidores de proteina cinasa y uso de los mismos. | |
| ATE427941T1 (de) | Thiazolderivate mit vap-1-hemmender wirkung | |
| TW200716531A (en) | Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia | |
| FR2942625B1 (fr) | Derives indoliques pour le traitement de maladies neurodegeneratives | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| EA200870089A1 (ru) | Применение производных бензоконденсированного гетероциклического сульфамида для лечения злоупотребления психоактивным веществом и аддикции | |
| AR060566A1 (es) | Tratamiento de melanoma | |
| ECSP045452A (es) | Compuestos para el tratamiento del ántrax e inhibidores del factor letal | |
| DK2065388T3 (da) | Pyrazolopyrimidinderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |